College of Medicine: Deans
Mark I. Rosenblatt, MD, PhD, MBA, MHA
Executive Dean, University of Illinois College of Medicine
Associate Vice Chancellor for Physician Affairs
Illinois Lions/Charles I. Young Chair in Ocular Research
Professor of Ophthalmology and Visual Sciences
Mark I. Rosenblatt, MD, PhD, MBA, MHA has served as Executive Dean of the University of Illinois College of Medicine since 2019. In May of 2023, Dr. Rosenblatt was appointed interim CEO of the University of Illinois Hospital and Clinics. Additionally, he has been Associate Vice Chancellor for Physician Affairs since 2022. Prior to becoming Executive Dean, Dr. Rosenblatt was appointed in 2014 as Illinois Lions/Charles I. Young Chair, Professor, and Head of the Department of Ophthalmology and Visual Sciences at the University of Illinois College of Medicine. In addition, he served as Director of the Medical Scientist Training Program from 2019 to 2022.
Dr. Rosenblatt is an internationally recognized clinician-scientist. As Director of the Corneal Regenerative Medicine Laboratory, he leads groups of scientists investigating the mechanism of corneal peripheral nerve regeneration following injury, and the use of nanoengineered biomaterials for use in stem cell delivery to the ocular surface. His work in regenerative medicine has been funded by the National Institutes of Health, the Department of Defense, Research to Prevent Blindness, the Falk Family Foundation, and the Tri-Institutional Stem Cell Initiative. Dr. Rosenblatt has published widely, including over 150 original manuscripts, review articles, book chapters, and abstracts.
Dr. Rosenblatt is a graduate of the University of Miami Miller School of Medicine’s Honors Program in Medical Education and the Combined MD/PhD program, receiving his PhD in Biochemistry, Cell, and Molecular Biology. He also completed his MBA at the New York University Stern School and his MHA at the University of Illinois Chicago School of Public Health. Dr. Rosenblatt completed his ophthalmology residency and combined clinical/research fellowship in corneal disease at the Massachusetts Eye and Ear Infirmary/Harvard Medical School. He is a member of the Alpha Omega Alpha and Omicron Delta Kappa honor societies.